Skip to content

S 6422 · New York · 2025-2026 · Billy

Skip to content

Home
/
Bills
/
New York
/
2025-2026
/
S 6422

New York · 2025-2026 session · senate

S 6422Relates to prescription labels for gonadotropin-releasing hormone agonists, pubertal suppressants, anabolic steroids, alpha reductase inhibitors, progestins, or drug classes for hormone replacement therapy

Status: In committee
Latest action: 2025-03-13 — REFERRED TO HIGHER EDUCATION
Primary sponsor: Brad Hoylman-Sigal

Track this bill

Sponsors

Brad Hoylman-Sigal · primaryprimary
Jeremy Cooney (Democratic/Working Families) · cosponsor

Versions

S6422—

Legislative history

Public legislative record via Billy. Sign in to track, annotate, and export work product.

About public bill pages Compare Billy New York bill RSS

Mar 13, 2025

REFERRED TO HIGHER EDUCATION

Official sources

Version 0PDF HTML

About this page

Is this the official New York bill page?: No — this is Billy’s public legislative record for S 6422. Official source links are listed above when publishers provide them.
Can I track updates?: Yes. Sign in to track S 6422, get alerts, annotate diffs, and export Word work product.